235 related articles for article (PubMed ID: 20063038)
21. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
22. Agonist-biased signaling at the sst2A receptor: the multi-somatostatin analogs KE108 and SOM230 activate and antagonize distinct signaling pathways.
Cescato R; Loesch KA; Waser B; Mäcke HR; Rivier JE; Reubi JC; Schonbrunn A
Mol Endocrinol; 2010 Jan; 24(1):240-9. PubMed ID: 19910453
[TBL] [Abstract][Full Text] [Related]
23. Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues--Observations in two patients with acromegaly and severe headache.
Marina D; Burman P; Klose M; Casar-Borota O; Luque RM; Castaño JP; Feldt-Rasmussen U
Growth Horm IGF Res; 2015 Oct; 25(5):262-7. PubMed ID: 26188991
[TBL] [Abstract][Full Text] [Related]
24. BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas.
Ibáñez-Costa A; López-Sánchez LM; Gahete MD; Rivero-Cortés E; Vázquez-Borrego MC; Gálvez MA; de la Riva A; Venegas-Moreno E; Jiménez-Reina L; Moreno-Carazo A; Tinahones FJ; Maraver-Selfa S; Japón MA; García-Arnés JA; Soto-Moreno A; Webb SM; Kineman RD; Culler MD; Castaño JP; Luque RM
Sci Rep; 2017 Feb; 7():42002. PubMed ID: 28181484
[TBL] [Abstract][Full Text] [Related]
25. Chronic treatment with estrogen up-regulates expression of sst2 messenger ribonucleic acid (mRNA) but down-regulates expression of sst5 mRNA in rat pituitaries.
Kimura N; Tomizawa S; Arai KN; Kimura N
Endocrinology; 1998 Apr; 139(4):1573-80. PubMed ID: 9528936
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin (SRIF) modulates distinct signaling pathways in rat pituitary tumor cells; negative coupling of SRIF receptor subtypes 1 and 2 to arachidonic acid release.
Cervia D; Fiorini S; Pavan B; Biondi C; Bagnoli P
Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):200-9. PubMed ID: 11882916
[TBL] [Abstract][Full Text] [Related]
27. Gene structure and regulation of the somatostatin receptor type 2.
Kraus J; Wöltje M; Schönwetter N; Höllt V
J Physiol Paris; 2000; 94(3-4):199-204. PubMed ID: 11087997
[TBL] [Abstract][Full Text] [Related]
28. Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro.
Zatelli MC; Piccin D; Tagliati F; Bottoni A; Ambrosio MR; Margutti A; Scanarini M; Bondanelli M; Culler MD; degli Uberti EC
J Mol Endocrinol; 2005 Oct; 35(2):333-41. PubMed ID: 16216913
[TBL] [Abstract][Full Text] [Related]
29. Identification of the receptors for somatostatin (SST) and cortistatin (CST) in chickens and investigation of the roles of cSST28, cSST14, and cCST14 in inhibiting cGHRH1-27NH2-induced growth hormone secretion in cultured chicken pituitary cells.
Meng F; Huang G; Gao S; Li J; Yan Z; Wang Y
Mol Cell Endocrinol; 2014 Mar; 384(1-2):83-95. PubMed ID: 24418361
[TBL] [Abstract][Full Text] [Related]
30. Development of selective antibodies against the human somatostatin receptor subtypes sst1-sst5.
Helboe L; Møller M; Nørregaard L; Schiødt M; Stidsen CE
Brain Res Mol Brain Res; 1997 Oct; 49(1-2):82-8. PubMed ID: 9387866
[TBL] [Abstract][Full Text] [Related]
31. The localization of somatostatin receptor 1 (sst1) immunoreactivity in the rat brain using an N-terminal specific antibody.
Hervieu G; Emson PC
Neuroscience; 1998 Aug; 85(4):1263-84. PubMed ID: 9681962
[TBL] [Abstract][Full Text] [Related]
32. Localization and pharmacological characterization of somatostatin sst2 sites in the rat cerebellum.
Piwko C; Thoss VS; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):607-13. PubMed ID: 9053731
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterisation of the goldfish somatostatin sst5 receptor.
Nunn C; Feuerbach D; Lin X; Peter R; Hoyer D
Eur J Pharmacol; 2002 Feb; 436(3):173-86. PubMed ID: 11858797
[TBL] [Abstract][Full Text] [Related]
34. The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells.
Molè D; Gentilin E; Ibañez-Costa A; Gagliano T; Gahete MD; Tagliati F; Rossi R; Pelizzo MR; Pansini G; Luque RM; Castaño JP; degli Uberti E; Zatelli MC
Endocrine; 2015 Nov; 50(2):442-52. PubMed ID: 25854304
[TBL] [Abstract][Full Text] [Related]
35. [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors.
Siehler S; Seuwen K; Hoyer D
Eur J Pharmacol; 1998 May; 348(2-3):311-20. PubMed ID: 9652348
[TBL] [Abstract][Full Text] [Related]
36. Regulation of neuronal nitric-oxide synthase activity by somatostatin analogs following SST5 somatostatin receptor activation.
Cordelier P; Estève JP; Najib S; Moroder L; Vaysse N; Pradayrol L; Susini C; Buscail L
J Biol Chem; 2006 Jul; 281(28):19156-71. PubMed ID: 16690617
[TBL] [Abstract][Full Text] [Related]
37. Development and use of a receptor antibody to characterize the interaction between somatostatin receptor subtype 1 and G proteins.
Gu YZ; Brown PJ; Loose-Mitchell DS; Stork PJ; Schonbrunn A
Mol Pharmacol; 1995 Dec; 48(6):1004-14. PubMed ID: 8847999
[TBL] [Abstract][Full Text] [Related]
38. Characterisation of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activity.
Siehler S; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):510-21. PubMed ID: 10598790
[TBL] [Abstract][Full Text] [Related]
39. Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors.
Sampedro-Núñez M; Luque RM; Ramos-Levi AM; Gahete MD; Serrano-Somavilla A; Villa-Osaba A; Adrados M; Ibáñez-Costa A; Martín-Pérez E; Culler MD; Marazuela M; Castaño JP
Oncotarget; 2016 Feb; 7(6):6593-608. PubMed ID: 26673010
[TBL] [Abstract][Full Text] [Related]
40. Characterization of cloned human somatostatin receptor SSTR5.
O'Carroll AM; Raynor K; Lolait SJ; Reisine T
Mol Pharmacol; 1994 Aug; 46(2):291-8. PubMed ID: 8078491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
